SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,895.74 315.20
( 0.43%)

Global Indices

Nasdaq

51,839.66 468.68
(0.91%)

Dow Jones

7,763.25 38.12
(0.49%)

Hang Seng

66,308.10 794.11
(1.21%)

Nikkei 225

10,694.57 14.58
(0.14%)

Forex

USD-INR

95.89 0.16
(0.16%)

EUR-INR

109.08 -0.12
(-0.11%)

GBP-INR

126.82 -0.30
(-0.24%)

JPY-INR

0.60 0.00
(-0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Nectar Lifescience Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532649

INE023H01027

29.975558

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NECLIFE

209.22

EPS(TTM)

Face Value()

Div & Yield %

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	0.00	0.00	1925.83	1746.56	1924.92	1762.27
Excise Duty	0.00	0.00	241.75	222.89	256.69	220.45
Net Sales	0.00	0.00	1684.08	1523.67	1668.23	1541.82
Other Income	9.29	1.88	14.58	43.18	11.32	3.79
Stock Adjustments	0.00	0.00	40.21	41.64	-14.97	-102.80
Total Income	9.29	1.88	1738.87	1608.49	1664.58	1442.81
EXPENDITURE :
Raw Materials	0.00	0.00	1242.45	1200.84	1207.32	1052.82
Power & Fuel Cost	0.10	0.05	129.52	127.39	101.41	84.63
Employee Cost	0.89	0.09	81.71	75.14	71.91	70.55
Other Manufacturing Expenses	0.01	0.00	55.30	44.88	45.09	44.16
Selling & Administrative Expenses	4.39	0.05	61.38	61.01	66.82	72.00
Miscellaneous Expenses	290.85	114.38	2.37	1.32	1.90	31.04
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	296.24	114.57	1572.73	1510.59	1494.44	1355.19
Operating Profit	-286.94	-112.69	166.13	97.91	170.13	87.63
Interest	36.13	0.00	87.14	79.48	78.81	112.03
Gross Profit	-323.07	-112.69	78.99	18.43	91.32	-24.40
Depreciation	0.34	0.62	60.72	59.12	56.97	60.25
Profit Before Tax	-323.41	-113.31	18.27	-40.69	34.35	-84.65
Tax	-30.53	0.38	13.27	-18.24	9.03	-11.50
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Net Profit	-292.89	-113.68	5.00	-22.46	25.32	-73.15
Extraordinary Items	-52.25	0.04	0.18	40.51	9.41	-25.41
Adjusted Net Profit	-240.64	-113.72	4.82	-62.97	15.91	-47.74
Adjustment below Net Profit	0.08	0.54	-0.34	0.19	0.81	0.00
P & L Balance brought forward	590.79	703.93	699.27	721.54	695.41	766.26
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	3.00	0.00	0.00	0.00	0.00	1.12
P & L Balance carried down	294.98	590.79	703.93	699.27	721.54	691.99
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	-15.08	-5.07	0.22	-1.00	1.13	-3.26
Earnings Per Share(Adj)-Unit Curr	-15.08	-5.07	0.22	-1.00	1.13	-3.26
Book Value-Unit Curr	29.98	42.63	47.68	47.47	48.46	47.30
Book Value(Adj)-Unit Curr	29.98	42.63	47.68	47.47	48.46	47.30

73,895.74 315.20 ( 0.43%)

51,839.66 468.68 (0.91%)

7,763.25 38.12 (0.49%)

66,308.10 794.11 (1.21%)

10,694.57 14.58 (0.14%)

95.89 0.16 (0.16%)

109.08 -0.12 (-0.11%)

126.82 -0.30 (-0.24%)

0.60 0.00 (-0.20%)